GenMark Diagnostics Reports Q1 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
GenMark Diagnostics (GNMK) Reports In-Line Q1 EPS, Maintains FY Outlook
May 5, 2015 4:55 PM EDTGenMark Diagnostics (NASDAQ: GNMK) reported Q1 EPS of ($0.24), in-line with the analyst estimate of ($0.24). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $10.1 million.
For full year 2015, the Company continues to expect revenue in the range of $38... More
